ARTICLE | Clinical News
Bradycor bradykinin antagonist: Filed to begin a Phase II
May 17, 1993 7:00 AM UTC
Cortech Inc. (CRTQ) Product: Bradycor bradykinin antagonist Indication: Intracranial pressure in head trauma Status: Filed to begin a Phase II pilot study ...